These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 23619365)

  • 1. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
    Halkein J; Tabruyn SP; Ricke-Hoch M; Haghikia A; Nguyen NQ; Scherr M; Castermans K; Malvaux L; Lambert V; Thiry M; Sliwa K; Noel A; Martial JA; Hilfiker-Kleiner D; Struman I
    J Clin Invest; 2013 May; 123(5):2143-54. PubMed ID: 23619365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
    Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
    Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microRNA links prolactin to peripartum cardiomyopathy.
    Yang Y; Rodriguez JE; Kitsis RN
    J Clin Invest; 2013 May; 123(5):1925-7. PubMed ID: 23619357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.
    Ricke-Hoch M; Bultmann I; Stapel B; Condorelli G; Rinas U; Sliwa K; Scherr M; Hilfiker-Kleiner D
    Cardiovasc Res; 2014 Mar; 101(4):587-96. PubMed ID: 24448315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Nonhoff J; Ricke-Hoch M; Mueller M; Stapel B; Pfeffer T; Kasten M; Scherr M; von Kaisenberg C; Bauersachs J; Haghikia A; Hilfiker-Kleiner D
    Cardiovasc Res; 2017 May; 113(6):598-608. PubMed ID: 28453725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.
    Kryczka KE; Demkow M; Dzielińska Z
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy.
    Cherubin S; Peoples T; Gillard J; Lakhal-Littleton S; Kurinczuk JJ; Nair M
    Open Heart; 2020 Oct; 7(2):. PubMed ID: 33060142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
    Hilfiker-Kleiner D; Kaminski K; Podewski E; Bonda T; Schaefer A; Sliwa K; Forster O; Quint A; Landmesser U; Doerries C; Luchtefeld M; Poli V; Schneider MD; Balligand JL; Desjardins F; Ansari A; Struman I; Nguyen NQ; Zschemisch NH; Klein G; Heusch G; Schulz R; Hilfiker A; Drexler H
    Cell; 2007 Feb; 128(3):589-600. PubMed ID: 17289576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripartum cardiomyopathy: a little known disease].
    Scardovi AB; De Maria R
    G Ital Cardiol (Rome); 2018 Apr; 19(4):209-221. PubMed ID: 29912235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.
    Zhu RR; Chen Q; Liu ZB; Ruan HG; Wu QC; Zhou XL
    J Cell Mol Med; 2020 Jul; 24(14):7907-7914. PubMed ID: 32529705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
    Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
    Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K
    Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in experimental peripartum cardiomyopathy.
    Pfeffer TJ; List M; Müller JH; Scherr M; Bauersachs J; Hilfiker-Kleiner D; Ricke-Hoch M
    ESC Heart Fail; 2021 Aug; 8(4):3375-3381. PubMed ID: 34002539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies.
    Ricke-Hoch M; Pfeffer TJ; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Mar; 116(3):520-531. PubMed ID: 31605117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
    Stapel B; Kohlhaas M; Ricke-Hoch M; Haghikia A; Erschow S; Knuuti J; Silvola JM; Roivainen A; Saraste A; Nickel AG; Saar JA; Sieve I; Pietzsch S; Müller M; Bogeski I; Kappl R; Jauhiainen M; Thackeray JT; Scherr M; Bengel FM; Hagl C; Tudorache I; Bauersachs J; Maack C; Hilfiker-Kleiner D
    Eur Heart J; 2017 Feb; 38(5):349-361. PubMed ID: 28201733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Peripartum Cardiomyopathy.
    Arany Z
    Annu Rev Med; 2018 Jan; 69():165-176. PubMed ID: 28813232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
    Patten IS; Rana S; Shahul S; Rowe GC; Jang C; Liu L; Hacker MR; Rhee JS; Mitchell J; Mahmood F; Hess P; Farrell C; Koulisis N; Khankin EV; Burke SD; Tudorache I; Bauersachs J; del Monte F; Hilfiker-Kleiner D; Karumanchi SA; Arany Z
    Nature; 2012 May; 485(7398):333-8. PubMed ID: 22596155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reviewing peripartum cardiomyopathy: current state of knowledge.
    Selle T; Renger I; Labidi S; Bultmann I; Hilfiker-Kleiner D
    Future Cardiol; 2009 Mar; 5(2):175-89. PubMed ID: 19371191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.